Country: Ирска
Језик: Енглески
Извор: HPRA (Health Products Regulatory Authority)
Allopurinol
Pinewood Laboratories Ltd,
M04AA; M04AA01
Allopurinol
100 milligram(s)
Tablet
Product subject to prescription which may be renewed (B)
Preparations inhibiting uric acid production; allopurinol
Not marketed
1982-11-01
PACKAGE LEAFLET: INFORMATION FOR THE USER Purinol 100 mg and 300 mg Tablets Allopurinol 24LF Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. • If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet 1. What Purinol Tablets are and what they are used for 2. What you need to know before you take Purinol Tablets 3. How to take Purinol Tablets 4. Possible side effects 5. How to store Purinol Tablets 6. Contents of the pack and other information 1. What Purinol Tablets are and what they are used for Purinol Tablets contain the active ingredient allopurinol, this belongs to a group of medicines called xanthine oxidase inhibitors, which act to control the speed at which certain chemical changes occur in the body. Purinol tablets are used to treat conditions in which there is too much uric acid in the body such as: • gout • certain types of kidney disease and kidney stones • cancer and some enzyme disorders which lead to the build up of uric acid (symptoms may include swelling and inflammation of the joints). 2. What you need to know before you take Purinol Tablets Do NOT take Purinol Tablets if you: • have had an allergic reaction to Purinol, allopurinol or any of the other ingredients (see section 6 and end of section 2) Warnings and precautions Talk to your doctor or pharmacist before taking Purinol Tablets if: • you are suffering, or suffered from liver or kidney disease • you are taking medicines for heart disease or high blood pressure, e.g. diuretics (water tablets) or ACE inhibitors • you are experiencing an acute attack of gout • you are of Han Chin Прочитајте комплетан документ
HealthProductsRegulatoryAuthority 27February2019 CRN008WVT Page1of11 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Purinol100mgTablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Eachtabletcontains100mgAllopurinol. Forafulllistofexcipientsseesection6.1. 3 PHARMACEUTICAL FORM Tablet White,biconvextabletsengraved1K1withabreaklineonthereverse. Thescorelineisonlytofacilitatebreakingforeaseof swallowingandnottodivideintoequalhalves. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Allopuriniolisindicatedforreducingurate/uricacidformationinconditionswhereurate/uricaciddepositionhasalready occurred(e.g.goutyarthritis,skintophi,nephrolithiasis)orisapredictableclinicalrisk(e.g.treatmentofmalignancypotentially leadingtoacuteuricacidnephropathy). Themainclinicalconditionswhereurate/uricaciddepositionmayoccurare: idiopathicgout; uricacidlithiasis; acuteuricacidnephropathy; neoplasticdiseaseandmyeloproliferativediseasewithhighcellturnoversrates,inwhichhighuratelevelsoccureither spontaneously,oraftercytotoxictherapy; certainenzymedisorderswhichleadtooverproductionofurate,forexample: - hypoxanthine-guaninephosphoribosyltransferase,includingLesch-Nyhansyndrome; - glucose-6-phosphataseincludingglycogenstoragedisease; - phosphoribosylpyrophosphatesynthetase; - phosphoribosylpyrophosphateaminotransferase; - adeninephosphoribosyltransferase; Allopurinolisindicatedforthemanagementof2,8-dihydroxyadenine(2,8-DHA)renalstonesrelatedtodeficientactivityof adeninephosphoribosyltransferase. Allopurinolis Прочитајте комплетан документ